Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Med Princ Pract ; 26(3): 201-217, 2017.
Article in English | MEDLINE | ID: mdl-28278495

ABSTRACT

The gastrointestinal tract digests and absorbs dietary nutrients, protects the body against physical and chemical damage from contents in its lumen, provides immunity against external antigens, and keeps an optimum environment for the gut microbiota. These functions cannot be performed normally in several diseases of which the following are discussed here: irritable bowel syndrome and inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Because these diseases are associated with oxidative stress, a host of antioxidant supplements are used for maintenance and recovery of the gut functions. However, the benefits of these supplements have not been established. The available 80 human trials were rated for levels of confidence and for benefits of the antioxidant supplements. For Crohn's disease, the supplements for which clear benefits occurred in at least 2 studies were allopurinol, Boswellia serrata (frankincense or shallaki), Artemesia species (wormwood), Tripterygium wilfordii (léi gong téng), and omega-3 fatty acids. Similar beneficial supplements for ulcerative colitis were allopurinol, Matricaria chamomilla (chamomile), Curcuma longa (curcumin in turmeric), and omega-3 fatty acids. There was also a clear benefit for ulcerative colitis in 2 studies where a multiherbal Chinese medicine preparation and an Ayurvedic medicine preparation were used. For irritable bowel syndrome, there was only a marginal benefit of some of the antioxidant supplements. Thus, some antioxidant supplements may be beneficial at certain stages of specific diseases. This is consistent with the current concept that antioxidants act by inhibiting oxidative stress pathways in a tissue- and environment-specific manner and not by simply acting as scavengers.


Subject(s)
Antioxidants/therapeutic use , Dietary Supplements , Inflammatory Bowel Diseases/drug therapy , Irritable Bowel Syndrome/drug therapy , Allopurinol/therapeutic use , Antioxidants/pharmacology , Colitis, Ulcerative/drug therapy , Crohn Disease/drug therapy , Fatty Acids, Omega-3/therapeutic use , Gastrointestinal Microbiome/physiology , Gastrointestinal Tract/physiopathology , Humans , Inflammatory Bowel Diseases/diagnosis , Irritable Bowel Syndrome/diagnosis , Medicine, Traditional/methods , Plants, Medicinal
2.
Nutr J ; 15: 1, 2016 Jan 05.
Article in English | MEDLINE | ID: mdl-26728196

ABSTRACT

Arthritis causes disability due to pain and inflammation in joints. There are many forms of arthritis, one of which is osteoarthritis whose prevalence increases with age. It occurs in various joints including hip, knee and hand with knee osteoarthritis being more prevalent. There is no cure for it. The management strategies include exercise, glucosamine plus chondroitin sulfate and NSAIDs. In vitro and animal studies provide a rationale for the use of antioxidant supplements for its management. This review assesses the reality of the benefits of antioxidant supplements in the management of knee osteoarthritis. Several difficulties were encountered in examining this issue: poorly conducted studies, a lack of uniformity in disease definition and diagnosis, and muddling of conclusions from attempts to isolate the efficacious molecules. The antioxidant supplements with most evidence for benefit for pain relief and function in knee osteoarthritis were based on curcumin and avocado-soya bean unsaponifiables. Boswellia and some herbs used in Ayurvedic and Chinese medicine may also be useful. The benefits of cuisines with the appropriate antioxidants should be assessed because they may be more economical and easier to incorporate into the lifestyle.


Subject(s)
Antioxidants/administration & dosage , Dietary Supplements , Osteoarthritis, Knee/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Boswellia/chemistry , Curcuma/chemistry , Humans , Medicine, Ayurvedic , Medicine, Chinese Traditional , Osteoarthritis, Knee/diagnosis , Persea/chemistry , Randomized Controlled Trials as Topic , Reactive Oxygen Species/metabolism , Glycine max/chemistry
3.
Med Princ Pract ; 24(3): 201-15, 2015.
Article in English | MEDLINE | ID: mdl-25791371

ABSTRACT

Obesity is a central health issue due to its epidemic prevalence and its association with type 2 diabetes and other comorbidities. Obesity is not just being overweight. It is a metabolic disorder due to the accumulation of excess dietary calories into visceral fat and the release of high concentrations of free fatty acids into various organs. It represents a state of chronic oxidative stress and low-grade inflammation whose intermediary molecules may include leptin, adiponectin and cytokines. It may progress to hyperglycemia, leading to type 2 diabetes. Whether or not dietary antioxidant supplements are useful in the management of obesity and type 2 diabetes is discussed in this review. Only the benefits for obesity and diabetes are examined here. Other health benefits of antioxidants are not considered. There are difficulties in comparing studies in this field because they differ in the time frame, participants' ethnicity, administration of antioxidant supplements, and even in how obesity was measured. However, the literature presents reasonable evidence for marginal benefits of supplementation with zinc, lipoic acid, carnitine, cinnamon, green tea, and possibly vitamin C plus E, although the evidence is much weaker for omega-3 polyunsaturated fatty acids, coenzyme Q10, green coffee, resveratrol, or lycopene. Overall, antioxidant supplements are not a panacea to compensate for a fast-food and video-game way of living, but antioxidant-rich foods are recommended as part of the lifestyle. Such antioxidant foods are commonly available.


Subject(s)
Antioxidants/therapeutic use , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Dietary Supplements , Obesity/complications , Obesity/drug therapy , Adipose Tissue/metabolism , Alpha-Ketoglutarate-Dependent Dioxygenase FTO , Antioxidants/pharmacology , Biomarkers , Body Mass Index , Diabetes Mellitus, Type 2/physiopathology , Fatty Acids, Nonesterified/metabolism , Genetic Predisposition to Disease , Humans , Inflammation/metabolism , Leptin/metabolism , Obesity/physiopathology , Overweight/complications , Overweight/drug therapy , Overweight/physiopathology , Oxidative Stress/physiology , Proprotein Convertase 1/genetics , Proteins/genetics , Reactive Oxygen Species/metabolism , Receptor, Melanocortin, Type 4/genetics , Vitamins/therapeutic use
4.
Mol Cell Biochem ; 388(1-2): 173-83, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24311110

ABSTRACT

A number of nutritional supplements containing antioxidants are advertised for better vision health. Do they benefit the average consumer? The literature was examined for the effectiveness of antioxidants for human eye health, and for the intricacies in collection of such evidence. The following diseases were considered: cataract, glaucoma, age-related macular degeneration (AMD), retinopathy, retinitis pigmentosa, eye infections, and uveitis. The literature indicates that antioxidant supplements plus lutein have a reasonable probability of retarding AMD. For glaucoma, such supplements were ineffectual in some studies but useful in others. In some studies, antioxidant rich fruits and vegetables were also useful for protection against glaucoma. For diabetic retinopathy, antioxidant supplements may have a small benefit, if any, but only as an adjunct to glycemic control. In very high-risk premature retinopathy and retinitis pigmentosa, antioxidant supplements may be beneficial but those with excess Vitamin E should be avoided. For cataract, there is no evidence for an advantage of such nutritional supplements. However, lubricant drops containing N-acetylcarnosine may be helpful in initial stages of the disease. For eye infections and other causes of uveitis, antioxidants have not been found useful. We recommend that a diet high in antioxidant rich foods should be developed as a habit from an early age. However, when initial signs of vision health deterioration are observed, the appropriate nutritional supplement products may be recommended but only to augment the primary medical treatments.


Subject(s)
Antioxidants/therapeutic use , Eye Diseases/diet therapy , Eye Diseases/drug therapy , Vision, Ocular/drug effects , Blindness/prevention & control , Cataract/diet therapy , Cataract/drug therapy , Dietary Supplements , Eye Infections/diet therapy , Eye Infections/drug therapy , Glaucoma/diet therapy , Glaucoma/drug therapy , Humans , Lutein/therapeutic use , Macular Degeneration/diet therapy , Macular Degeneration/drug therapy , Reactive Oxygen Species , Retinitis Pigmentosa/diet therapy , Retinitis Pigmentosa/drug therapy , Vitamins/therapeutic use
5.
Biochim Biophys Acta ; 1818(3): 730-7, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22178645

ABSTRACT

Na(+)- Ca(2+) exchanger (NCX) has been proposed to play a role in refilling the sarco/endoplasmic reticulum (SER) Ca(2+) pool along with the SER Ca(2+) pump (SERCA). Here, SERCA inhibitor thapsigargin was used to determine the effects of SER Ca(2+) depletion on NCX-SERCA interactions in smooth muscle cells cultured from pig coronary artery. The cells were Na(+)-loaded and then placed in either a Na(+)-containing or in a Na(+)-substituted solution. Subsequently, the difference in Ca(2+) entry between the two groups was examined and defined as the NCX mediated Ca(2+) entry. The NCX mediated Ca(2+) entry in the smooth muscle cells was monitored using two methods: Ca(2+)sensitive fluorescence dye Fluo-4 and radioactive Ca(2+). Ca(2+)-entry was greater in the Na(+)-substituted cells than in the Na(+)-containing cells when measured by either method. This difference was established to be NCX-mediated as it was sensitive to the NCX inhibitors. Thapsigargin diminished the NCX mediated Ca(2+) entry as determined by either method. Immunofluorescence confocal microscopy was used to determine the co-localization of NCX1 and subsarcolemmal SERCA2 in the cells incubated in the Na(+)-substituted solution with or without thapsigargin. SER Ca(2+) depletion with thapsigargin increased the co-localization between NCX1 and the subsarcolemmal SERCA2. Thus, inhibition of SERCA2 leads to blockade of constant Ca(2+) entry through NCX1 and also increases proximity between NCX1 and SERCA2. This blockade of Ca(2+) entry may protect the cells against Ca(2+)-overload during ischemia-reperfusion when SERCA2 is known to be damaged.


Subject(s)
Calcium/metabolism , Coronary Vessels/metabolism , Enzyme Inhibitors/pharmacology , Muscle, Smooth, Vascular/metabolism , Sodium-Calcium Exchanger , Sodium/metabolism , Thapsigargin/pharmacology , Animals , Coronary Vessels/pathology , Ion Transport/drug effects , Muscle, Smooth, Vascular/pathology , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Sarcolemma/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/antagonists & inhibitors , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Sodium-Calcium Exchanger/antagonists & inhibitors , Sodium-Calcium Exchanger/metabolism , Swine
6.
Biochim Biophys Acta ; 1808(3): 589-96, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21130729

ABSTRACT

Pig coronary artery smooth muscle expresses, among many other proteins, Na+-Ca²+-exchanger NCX1 and sarcoplasmic reticulum Ca²+ pump SERCA2. NCX1 has been proposed to play a role in refilling the sarcoplasmic reticulum Ca²+ pool suggesting a functional linkage between the two proteins. We hypothesized that this functional linkage may require close apposition of SERCA2 and NCX1 involving regions of plasma membrane like lipid rafts. Lipid rafts are specialized membrane microdomains that appear as platforms to co-localize proteins. To determine the distribution of NCX1, SERCA2 and lipid rafts, we isolated microsomes from the smooth muscle tissue, treated them with non-ionic detergent and obtained fractions of different densities by sucrose density gradient centrifugal flotation. We examined the distribution of NCX1; SERCA2; non-lipid raft plasma membrane marker transferrin receptor protein; lipid raft markers caveolin-1, flotillin-2, prion protein, GM1-gangliosides and cholesterol; and cytoskeletal markers clathrin, actin and myosin. Distribution of markers identified two subsets of lipid rafts that differ in their components. One subset is rich in caveolin-1 and flotillin-2 and the other in GM1-gangliosides, prion protein and cholesterol. NCX1 distribution correlated strongly with SERCA2, caveolin-1 and flotillin-2, less strongly with the other membrane markers and negatively with the cytoskeletal markers. These experiments were repeated with a non-detergent method of treating microsomes with sonication at high pH and similar results were obtained. These observations are consistent with the observed functional linkage between NCX1 and SERCA2 and suggest a role for NCX1 in supplying Ca²+ for refilling the sarcoplasmic reticulum.


Subject(s)
Cell Membrane/metabolism , Coronary Vessels/metabolism , Membrane Microdomains/metabolism , Muscle, Smooth/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Sodium-Calcium Exchanger/metabolism , Animals , Blotting, Western , Calcium/metabolism , Caveolin 1/metabolism , Cholesterol/metabolism , Coronary Vessels/cytology , Cytoskeleton/metabolism , Gangliosidoses/metabolism , Ion Transport , Membrane Proteins/metabolism , Microsomes/metabolism , Muscle, Smooth/cytology , Prions/metabolism , Swine
8.
Mol Cell Biochem ; 339(1-2): 293-300, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20155488

ABSTRACT

Pig coronary artery smooth muscle expresses the Na(+)-Ca(2+)-exchanger NCX1 and the sarco/endoplasmic reticulum (SER) Ca(2+) pump SERCA2. NCX has been proposed to play a role in refilling the SER Ca(2+) pool. Caveolae may also direct Ca(2+) traffic during cell signaling. Here, we use immunofluorescence microscopy to determine if there is proximity between NCX1, SERCA2, and the caveolar protein caveolin-1. Stacks of images of cell surface domains were analyzed. Image stacks for one protein were analyzed for overlap with another protein, with and without randomization or image shifting. Within the resolution of light microscopy, there is significant overlap in the distributions of NCX1, SERCA2, and caveolin-1 but the three proteins are not always co-localized. The proximity between NCX1, SERCA2 is consistent with the assertion that NCX may supply Ca(2+) for refilling the SER but this relationship is only partial. Similarly, caveolae may direct traffic in some Ca(2+) signaling pathways but not others.


Subject(s)
Calcium/metabolism , Coronary Vessels/metabolism , Muscle, Smooth/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Sodium-Calcium Exchanger/metabolism , Animals , Caveolin 1/metabolism , Coronary Vessels/cytology , Microscopy, Fluorescence , Muscle, Smooth/cytology , Swine
9.
J Cell Mol Med ; 13(9B): 3742-52, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19659456

ABSTRACT

We tested the hypothesis that the de-endothelialized artery rings from the left anterior descending (LAD) coronary artery and its left ventricular branch (LVB) differ in their contractile responses to Na(+)-Ca(2+)-exchanger (NCX) mediated Ca(2+)-entry, muscarinic receptor activation with carbachol, and sarco/endoplasmic reticulum Ca(2+) pump (SERCA) inhibition with thapsigargin. In LVB, the force of contraction (in N/g tissue) produced by the NCX mediated Ca(2+)-entry (17.5 +/- 1.4) and carbachol (18 +/- 1.5) was only slightly smaller than that due to membrane depolarization with KCl (24.0 +/- 1.0). In contrast, in LAD the force of contraction produced with NCX (8.7 +/- 0.7) and carbachol (6.1 +/- 1.1) was much smaller than with KCl (15.7 +/- 0.7). Thapsigargin also contracted LVB with greater force than LAD. When isolated microsomes were used, the binding to the muscarinic receptor antagonist quinuclidinyl benzilate was greater in LVB than in LAD. Microsomes were also used for Western blots. The intensities of signals for both SERCA and NCX were greater in LVB than in LAD. These biochemical observations were consistent with the contractile experiments. Thus, it appears that the differences between LAD and the resistance arteries may begin as early as LVB.


Subject(s)
Calcium/metabolism , Coronary Vessels/pathology , Heart Ventricles/pathology , Myocardial Contraction , Sarcoplasmic Reticulum Calcium-Transporting ATPases/biosynthesis , Sodium-Calcium Exchanger/metabolism , Sodium/metabolism , Animals , Carbachol/pharmacology , Endoplasmic Reticulum/metabolism , Microsomes/metabolism , Muscle, Smooth/pathology , Myocardium/metabolism , Receptors, Muscarinic/metabolism , Sarcoplasmic Reticulum/metabolism , Swine , Thapsigargin/pharmacology
10.
J Cell Mol Med ; 13(8B): 1775-1783, 2009 Aug.
Article in English | MEDLINE | ID: mdl-18752635

ABSTRACT

An increase in cytosolic Ca(2+) concentration in coronary artery smooth muscle causes a contraction but in endothelium it causes relaxation. Na(+)-Ca(2+)-exchanger (NCX) may play a role in Ca(2+) dynamics in both the cell types. Here, the NCX-mediated (45)Ca(2+) uptake was compared in Na(+)-loaded pig coronary artery smooth muscle and endothelial cells. In both the cell types, this uptake was inhibited by KB-R7943, SEA 0400 and by monensin, but not by cariporide. Prior loading of the cells with the Ca(2+) chelator BAPTA increased the NCX-mediated (45)Ca(2+) uptake in smooth muscle but not in endothelial cells. In the presence or absence of BAPTA loading, the Na(+)-mediated (45)Ca(2+) uptake was greater in endothelial than in smooth muscle cells. In smooth muscle cells without BAPTA loading, thapsigargin diminished the NCX-mediated (45)Ca(2+) entry. This effect was not observed in endothelial cells or in either cell type after BAPTA loading. The results in the smooth muscle cells are consistent with a limited diffusional space model in which the NCX-mediated (45)Ca(2+) uptake was enhanced by chelation of cytosolic Ca(2+) or by its sequestration by the sarco/endoplasmic reticulum Ca(2+) pump (SERCA). They suggest a functional linkage between NCX and SERCA in the smooth muscle but not in the endothelial cells. The concept of a linkage between NCX and SERCA in smooth muscle was also confirmed by similar distribution of NCX and SERCA2 proteins when detergent-treated microsomes were fractionated by flotation on sucrose density gradients. Thus, the coronary artery smooth muscle and endothelial cells differ not only in the relative activities of NCX but also in its functional linkage to SERCA.


Subject(s)
Coronary Vessels/physiology , Endothelium, Vascular/metabolism , Muscle, Smooth/metabolism , Sodium-Calcium Exchanger/physiology , Animals , Calcium/metabolism , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/enzymology , Muscle, Smooth/cytology , Muscle, Smooth/enzymology , Swine
11.
Br J Pharmacol ; 147(2): 131-9, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16331296

ABSTRACT

1.--The addition of Ca(2+) ionophore A23187 or ATP to freshly isolated or cultured pig coronary artery endothelial cells (PCEC) potentiated the release of ascorbate (Asc). Cultured PCEC were used to characterize the Ca(2+)-mediated release. An increase in Ca(2+)-mediated Asc release was observed from PCEC preincubated with Asc, Asc-2-phosphate or dehydroascorbic acid (DHAA). 2.--The effects of various ATP analogs and inhibition by suramin were consistent with the ATP-induced release being mediated by P2Y2-like receptors. 3.--ATP-stimulated Asc release was Ca(2+)-mediated because (a) ATP analogs that increased Asc release also elevated cytosolic [Ca(2+)], (b) Ca(2+) ionophore A23187 and cyclopiazonic acid stimulated the Asc release, (c) removing extracellular Ca(2+) and chelating intracellular Ca(2+)inhibited the ATP-induced release, and (d) inositol-selective phospholipase C inhibitor U73122 also inhibited this release. 4.--Accumulation of Asc by PCEC was examined at Asc concentrations of 10 microM (Na(+)-Asc symporter not saturated) and 5 mM (Na(+)-Asc symporter saturated). At 10 microM Asc, A23187 and ATP caused an inhibition of Asc accumulation but at 5 mM Asc, both the agents caused a stimulation. Substituting gluconate for chloride did not affect the basal Asc uptake but it abolished the effects of A23187. 5.--PCEC but not pig coronary artery smooth muscle cells show a Ca(2+)- mediated Asc release pathway that may be activated by agents such as ATP.


Subject(s)
Antioxidants/metabolism , Ascorbic Acid/metabolism , Calcium/physiology , Coronary Vessels/metabolism , Endothelial Cells/metabolism , Adenosine Triphosphate/pharmacology , Adenosine Triphosphate/physiology , Animals , Calcimycin/pharmacology , Calcium/metabolism , Cells, Cultured , Coronary Vessels/cytology , Endothelial Cells/drug effects , In Vitro Techniques , Ionophores/pharmacology , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Swine
12.
Eur J Pharmacol ; 548(1-3): 36-44, 2006 Oct 24.
Article in English | MEDLINE | ID: mdl-16962579

ABSTRACT

In endothelial cells, anion channels open upon osmotic swelling during shear stress and hypotonic shock. Therefore, we examined the effects of hypotonic shock on release of the antioxidant anion ascorbate from pig coronary artery endothelial cells. Hypotonic shock potentiated ascorbate release from freshly isolated or cultured pig coronary artery endothelial cells; subsequently cultured endothelial cells were used. The hypotonic shock-induced increase in Asc release was rapid, depended on the degree of hypotonic shock, and not due to membrane leakiness. Stimulating P2Y2 like receptors in endothelial cells with ATP causes ascorbate release via a Ca2+ -mediated pathway. Hypotonic shock-induced release differed from the Ca2+-mediated Asc release because: (a) the increase in release with hypotonic shock was additive to that with ATP or A23187 (Ca2+ -ionophore), (b) apyrase, suramin or removing extracellular Ca2+ did not affect the hypotonic shock-stimulated release, (c) anion channel blockers inhibited the release by the two pathways differently, and (d) hypotonic shock increased the ascorbate release from endothelial cells and cultured smooth muscle cells whereas the Ca2+ -mediated ascorbate release occurred only in endothelial cells. Accumulation of ascorbate by endothelial cells was examined at extracellular ascorbate concentrations of 10 (Na+ -ascorbate symporter not saturated) and 5000 microM (Na+ -ascorbate symporter saturated). Hypotonic shock and A23187 decreased ascorbate accumulation at 10 microM ascorbate but increased it at 5000 microM. The effects of the two treatments were additive and also differed from each other with substitution of gluconate for extracellular chloride. Thus, ascorbate release from endothelial cells can be potentiated by two distinct pathways - hypotonic shock mediated and ATP/Ca2+ stimulated.


Subject(s)
Ascorbic Acid/metabolism , Endothelial Cells/metabolism , Adenosine Triphosphate/pharmacology , Animals , Antioxidants/metabolism , Calcimycin/pharmacology , Calcium , Coronary Vessels/cytology , Coronary Vessels/metabolism , Endothelial Cells/drug effects , Hypotonic Solutions/pharmacology , Osmotic Pressure , Swine
13.
Cell Calcium ; 36(1): 77-82, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15126058

ABSTRACT

We examined the effects of peroxynitrite pre-treatment on sarco/endoplasmic reticulum Ca(2+) (SERCA) pump in pig coronary artery smooth muscle and endothelium. In saponin-permeabilized cells, smooth muscle showed much greater rates of the SERCA Ca(2+) pump-dependent (45)Ca(2+) uptake/mg protein than did the endothelial cells. Peroxynitrite treatment of cells inhibited the SERCA pump more severely in smooth muscle cells than in endothelial cells. To determine implications of this observation, we next examined the effect of the SERCA pump inhibitor cyclopiazonic acid (CPA) on intracellular Ca(2+) concentration of intact cultured cells. CPA produced cytosolic Ca(2+) transients in cultured endothelial and smooth muscle cells. Pre-treatment with peroxynitrite (200 microM) inhibited the Ca(2+) transients in the smooth muscle but not in the endothelial cells. CPA contracts de-endothelialized artery rings and relaxes precontracted arteries with intact endothelium. Peroxynitrite (250 microM) pre-treatment inhibited contraction in the de-endothelialized artery rings, but not the endothelium-dependent relaxation. Thus, endothelial cells appear to be more resistant than smooth muscle to the effects of peroxynitrite at the levels of SERCA pump activity, CPA-induced Ca(2+) transients in cultured cells, and the effects of CPA on contractility. The greater resistance of endothelium to peroxynitrite may play a protective role in pathological conditions such as ischemia-reperfusion when excess free radicals are produced.


Subject(s)
Calcium-Transporting ATPases/metabolism , Endoplasmic Reticulum/drug effects , Endothelium, Vascular/physiology , Muscle, Smooth, Vascular/physiology , Peroxynitrous Acid/pharmacology , Animals , Calcium/metabolism , Calcium-Transporting ATPases/drug effects , Coronary Vessels/enzymology , Coronary Vessels/metabolism , Coronary Vessels/physiology , Endoplasmic Reticulum/metabolism , Endothelium, Vascular/drug effects , Enzyme Inhibitors/pharmacology , Indoles/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases , Swine
14.
Cell Calcium ; 34(1): 69-74, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12767894

ABSTRACT

We examined the effects of peroxynitrite pretreatment of pig coronary arteries on their sarcoplasmic reticulum (SR) Ca(2+) pump function. Pretreating rings from de-endothelialized arteries with peroxynitrite, followed by a wash to remove this agent, led to a decrease in the force of contraction produced in response to the SR Ca(2+) pump inhibitor cyclopiazonic acid (CPA, IC(50) = 87 +/- 6 microM). Inclusion of catalase and superoxide dismutase with the peroxynitrite did not alter its effect indicating that the inhibition was produced by peroxynitrite. Contractions produced by 30 mM KCl were not affected by up to 250 microM peroxynitrite. Smooth muscle cells cultured from this artery gave a transient increase in cytosolic Ca(2+) in response to CPA. Treating the cells with peroxynitrite inhibited this increase. Treating the SR-enriched isolated subcellular membrane fraction with peroxynitrite produced an inhibition of the ATP-dependent azide-insensitive oxalate-stimulated Ca(2+) uptake. Thus, peroxynitrite damages the SR Ca(2+)pump in the coronary artery, and this inhibition appears to lead to an inability of the arteries to respond to CPA. Thus, peroxynitrite produced from superoxide and NO in the arteries may compromise regulation of coronary tone which requires mobilization of Ca(2+) from the SR.


Subject(s)
Calcium Signaling/physiology , Calcium-Transporting ATPases/metabolism , Coronary Vessels/metabolism , Muscle, Smooth, Vascular/metabolism , Peroxynitrous Acid/metabolism , Adenosine Triphosphate/metabolism , Animals , Calcium/metabolism , Calcium Signaling/drug effects , Calcium-Transporting ATPases/drug effects , Coronary Vessels/drug effects , Enzyme Inhibitors/pharmacology , Indoles/pharmacology , Intracellular Membranes/drug effects , Intracellular Membranes/metabolism , Intracellular Membranes/ultrastructure , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle, Smooth, Vascular/drug effects , Nitric Oxide/metabolism , Peroxynitrous Acid/pharmacology , Potassium Chloride/pharmacology , Reperfusion Injury/metabolism , Reperfusion Injury/physiopathology , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum/metabolism , Superoxides/metabolism , Sus scrofa , Vasoconstriction/drug effects , Vasoconstriction/physiology
15.
Cell Calcium ; 51(2): 149-54, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22206647

ABSTRACT

The sarco/endoplasmic reticulum (SER) Ca(2+) pool is refilled by the SER Ca(2+) pump (SERCA) using cytosolic Ca(2+) and/or extracellular Ca(2+) entering the cell. The effects of the SERCA pump inhibitor cyclopiazonic acid (CPA) were studied in pig coronary artery smooth muscle using two protocols. In protocol A, the SERCA pump was inhibited by adding CPA to cells/tissues in Ca(2+)-containing solution, whereas in protocol B, CPA was added to cells/tissues in Ca(2+)-free solution, followed by reintroduction of extracellular Ca(2+). Addition of CPA increased cytosolic Ca(2+) in cultured smooth muscle cells and elicited contraction in de-endothelialized coronary arteries in both protocols. Based on pharmacological experiments, the CPA-induced contraction of de-endothelialized arteries in protocol B resulted from store operated Ca(2+) entry (SOCE). Reactive oxygen species such as peroxides are known to damage the SERCA pump in this tissue. Consistently, CPA-induced contractions were decreased in arteries pre-treated with hydrogen peroxide in protocol A. However, this pretreatment also decreased the force of contraction due to SOCE in protocol B, suggesting that it closed SOCE. We propose that the closure of SOCE triggered by exposure to reactive oxygen species may be a protective mechanism, so that Ca(2+) entry by this pathway is disallowed when SERCA is damaged in pathologies such as ischemia-reperfusion.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Calcium/metabolism , Coronary Vessels/metabolism , Indoles/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Animals , Coronary Vessels/pathology , Cytosol/metabolism , Hydrogen Peroxide/pharmacology , Muscle, Smooth, Vascular/pathology , Muscle, Smooth, Vascular/physiopathology , Myocardial Reperfusion Injury/metabolism , Myocardial Reperfusion Injury/pathology , Myocardial Reperfusion Injury/physiopathology , Oxidants/pharmacology , Swine
16.
J Cell Mol Med ; 11(1): 129-38, 2007.
Article in English | MEDLINE | ID: mdl-17367507

ABSTRACT

Vascular endothelial cells (EC) and smooth muscle cells (SMC) require a decrease in cytoplasmic Ca2+ concentration after activation. This can be achieved by Ca2+ sequestration by the sarco-/endoplasmic reticulum Ca2+ pumps (SERCA) and Ca2+ extrusion by plasma membrane Ca2+ pumps (PMCA) and Na+-Ca2+-exchangers (NCX). Since the two cell types differ in their structure and function, we compared the activities of PMCA, NCX and SERCA in pig coronary artery EC and SMC, the types of isoforms expressed using RT-PCR, and their protein abundance using Western blots. The activity of NCX is higher in EC than in SMC but those of PMCA and SERCA is lower. Consistently, the protein abundance for NCX protein is higher in EC than in SMC and those of PMCA and SERCA is lower. Based on RT-PCR experiments, the types of RNA present are as follows: EC for PMCA1 while SMC for PMCA4 and PMCA1; EC for SERCA2 and SERCA3 and SMC for SERCA2. Both EC and SMC express NCX1 (mainly NCX1.3). PMCA, SERCA and NCX differ in their affinities for Ca2+ and regulation. Based on these observations and the literature, we conclude that the tightly regulated Ca2+ removal systems in SMC are consistent with the cyclical control of contractility of the filaments and those in EC are consistent with Ca2+ regulation of the endothelial nitric oxide synthase near the cell surface. The differences between EC and SMC should be considered in therapeutic interventions of cardiovascular diseases.


Subject(s)
Coronary Vessels/cytology , Endothelium, Vascular/physiology , Muscle, Smooth/physiology , Plasma Membrane Calcium-Transporting ATPases/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Sodium-Calcium Exchanger/metabolism , Animals , Plasma Membrane Calcium-Transporting ATPases/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sarcoplasmic Reticulum Calcium-Transporting ATPases/genetics , Sodium-Calcium Exchanger/genetics , Swine
17.
Mol Cell Biochem ; 271(1-2): 43-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15881654

ABSTRACT

Although smooth muscle and endothelial cells in pig coronary artery are morphologically and functionally distinct, ascorbate uptake has been characterized only in smooth muscle cells. Ascorbate transporters in kidney and intestinal epithelial cells differ from those in smooth muscle. We examined ascorbate transport and mRNA expression of sodium-dependent vitamin C transporters (SVCT) by RT-PCR in the pig coronary artery endothelial cell cultures. When 14C-ascorbate uptake in endothelial cells was examined as 14C or by HPLC, the two values did not differ from each other. 14C-ascorbate uptake was Na(+)-dependent, stereoselective for L-ascorbate and inhibited by sulfinpyrazone. The kinetic characteristics of the uptake were: Km = 27 +/- 3 microM (Hill coefficient = 1) for ascorbate and Km = 73 +/- 14 mM (Hill coefficient = 2) for Na+. Surprisingly, endothelial cells had similar kinetic parameters as smooth muscle cells, except for a slightly lower uptake velocity in endothelial cells. Comparison with the smooth muscle showed that both tissue types expressed mRNA for SVCT2. Endothelial cells differ from epithelial cells which express mainly SVCT1 but resemble smooth muscle cells in this respect.


Subject(s)
Ascorbic Acid/pharmacokinetics , Coronary Vessels/cytology , Coronary Vessels/metabolism , Animals , Biological Transport/drug effects , Cells, Cultured , Coronary Vessels/drug effects , Dehydroascorbic Acid/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Molecular Sequence Data , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/metabolism , Organic Anion Transporters, Sodium-Dependent/genetics , Organic Anion Transporters, Sodium-Dependent/metabolism , Sodium/metabolism , Sodium-Coupled Vitamin C Transporters , Sulfinpyrazone/pharmacology , Swine , Symporters/genetics , Symporters/metabolism , Time Factors
18.
Am J Physiol Cell Physiol ; 285(6): C1537-43, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14600079

ABSTRACT

Sarco(endo)plasmic reticulum Ca2+ (SERCA) pumps are important for cell signaling. Three different genes, SERCA1, 2, and 3, encode these pumps. Most tissues, including vascular smooth muscle, express a splice variant of SERCA2 (SERCA2b), whereas SERCA3a is widely distributed in tissues such as vascular endothelium, tracheal epithelium, mast cells, and lymphoid cells. SERCA2b protein is readily inactivated by peroxynitrite that may be formed during cardiac ischemia reperfusion or during immune response after infection. Here, we compared the peroxynitrite sensitivity of SERCA2b and SERCA3a by using microsomes prepared from HEK-293T cells overexpressing the pumps. We incubated the microsomes with different concentrations of peroxynitrite and determined Ca2+ uptake, Ca2+-Mg2+-ATPase, Ca2+-dependent formation of acylphosphate intermediate, and protein mobility in Western blots. Ca2+ uptake, Ca2+-Mg2+-ATPase, and Ca2+-dependent formation of acylphosphate intermediate were inactivated for both SERCA2b and SERCA3a, but the latter was more resistant to the inactivation. Western blots showed that SERCA2b and SERCA3a proteins oligomerized after treatment with peroxynitrite, but each with a slightly different pattern. Compared with monomers, the oligomers may be less efficient in forming the acylphosphate intermediate and in conducting the remainder of the steps in the reaction cycle. We conclude that the resistance of SERCA3a to peroxynitrite may aid the cells expressing them in functioning during exposure to oxidative stress.


Subject(s)
Calcium-Transporting ATPases/drug effects , Peroxynitrous Acid/pharmacology , Animals , Blotting, Western , Ca(2+) Mg(2+)-ATPase/drug effects , Ca(2+) Mg(2+)-ATPase/metabolism , Calcium/metabolism , Cell Line, Transformed , Endoplasmic Reticulum/drug effects , Humans , Microsomes/drug effects , Oxidative Stress/physiology , Protein Isoforms/drug effects , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum Calcium-Transporting ATPases
19.
Am J Physiol Cell Physiol ; 284(2): C294-301, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12529249

ABSTRACT

Peroxynitrite generated in arteries from superoxide and NO may damage Ca(2+) pumps. Here, we report the effects of peroxynitrite on ATP-dependent azide-insensitive uptake of Ca(2+) into pig coronary artery vesicular membrane fractions F2 [enriched in plasma membrane (PM)] and F3 [enriched in sarcoplasmic reticulum (SR)]. Membranes were pretreated with peroxynitrite and then with DTT to quench this agent. This pretreatment inhibited Ca(2+) uptake in a peroxynitrite concentration-dependent manner, but the effect was more severe in F3 than in F2. The inhibition was thus not overcome by excess DTT used to quench peroxynitrite and was not affected if catalase, SOD, or mannitol was added along with peroxynitrite. Such damage to the pump protein would be difficult to repair if produced during ischemia-reperfusion. The acylphosphates formed with ATP in F3 corresponded mainly to the SR Ca(2+) pump (110 kDa), but in F2 both PM (140 kDa) and 110-kDa bands were observed. Peroxynitrite treatment of F2 inhibited only the 110-kDa band. Inhibition of Ca(2+) uptake and acylphosphate formation from ATP correlated well in peroxynitrite-treated F3 samples. However, inhibition of acylphosphates from orthophosphate (reverse reaction of the pump) was slightly poorer. Peroxynitrite treatment also covalently cross-linked the pump protein, yielding no dimers but only larger oligomers. In contrast, cross-linking of the SR Ca(2+) pump in skeletal and cardiac muscles gives dimers as the first oligomers. Therefore, we speculate that SERCA2 has a different quaternary structure in the coronary artery smooth muscle.


Subject(s)
Calcium-Transporting ATPases/metabolism , Coronary Vessels/metabolism , Dithiothreitol/analogs & derivatives , Muscle, Smooth, Vascular/metabolism , Peroxynitrous Acid/metabolism , Reactive Oxygen Species/metabolism , Sarcoplasmic Reticulum/metabolism , Acid Anhydride Hydrolases/drug effects , Acid Anhydride Hydrolases/metabolism , Adenosine Triphosphate/metabolism , Animals , Calcium Signaling/drug effects , Calcium Signaling/physiology , Calcium-Transporting ATPases/drug effects , Cation Transport Proteins , Cell Membrane/drug effects , Cell Membrane/metabolism , Coronary Artery Disease/metabolism , Coronary Artery Disease/physiopathology , Coronary Vessels/drug effects , Dithiothreitol/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Muscle, Smooth, Vascular/drug effects , Oxidative Stress/drug effects , Oxidative Stress/physiology , Peroxynitrous Acid/pharmacology , Plasma Membrane Calcium-Transporting ATPases , Reperfusion Injury/metabolism , Reperfusion Injury/physiopathology , Sarcoplasmic Reticulum/drug effects , Sarcoplasmic Reticulum Calcium-Transporting ATPases , Subcellular Fractions , Sus scrofa , Acylphosphatase
20.
Mol Cell Biochem ; 250(1-2): 197-201, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12962158

ABSTRACT

Here, we report that the smooth muscle and endothelium of the pig coronary artery differ in the profiles of energy metabolism nucleotides. ATP levels in the freshly isolated smooth muscle (1490 +/- 93, all the values are in pmol/mg protein) were significantly greater than in the endothelium (418 +/- 68). In contrast, endothelium contained higher levels of NADH (328 +/- 21), NAD+ (1210 -/+ 28), NADPH (87 +/- 2), and NADP+ (77 +/- 4) than smooth muscle (17 +/- 2, 96 +/- 14, 7 +/- 1, and 8 +/- 1, respectively). However, smooth muscle and endothelium do not differ from each other in the ratios of NADH/NAD+ or NADPH/NADP+. Cells cultured from smooth muscle and endothelium contained less ATP (93 +/- 2, 141 +/- 6) and had lower ratios of NADH/ NAD+ than the freshly isolated tissues but the NADPH/NADP+ ratios remained similar. We conclude that (a) freshly isolated smooth muscle and endothelium differ in their profiles of the energy metabolism nucleotides, and (b) culturing the cells alters the profile.


Subject(s)
Coronary Vessels/metabolism , Endothelium, Vascular/metabolism , Muscle, Smooth, Vascular/metabolism , Adenosine Triphosphate/metabolism , Animals , Cell Differentiation , Cells, Cultured , Myocardium/metabolism , NAD/metabolism , NADP/metabolism , Nicotine/metabolism , Swine
SELECTION OF CITATIONS
SEARCH DETAIL